In part 1 of this three-part series, behavioral science reveals how slow patient recruitment and enrollment challenges often ...
In today's ACT Brief, we examine Thermo Fisher's acquisition of Clario to expand clinical trial data infrastructure, how ...
In this video interview, Del Smith, PhD, CEO and co-founder of Acclinate, examines the structural and relational barriers ...
Thermo Fisher Scientific has completed its acquisition of Clario Holdings for $8.875 billion in cash, plus potential ...